ArticleACS medicinal chemistry letters2026

Novel Compounds as SARS-CoV‑2 Main Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections.

Ram W SabnisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.